Affiliation:
1. Universidade Federal de São Paulo
Abstract
Abstract:Objective: To characterize adverse events in cells, tissue, and organs donation, and transplantation notified in the state of São Paulo, Brazil. Method: Descriptive study with quantitative approach. Data provided by Transplantation Central of São Paulo from the “Individual notification form of adverse reactions in Biovigilance”, of the FormSUS platform, between 2016 and 2019, and categorized according to the nomenclature recommended by the World Health Organization regarding nature and type of event, severity, and imputability. Analysis was performed using descriptive statistics. Results: Fifty-two notifications were characterized, 90.4% related to the recipient, 78.8% from allogeneic procedures, 48.2% related to organs, and 44.2% to hematopoietic stem cells. The causes of notifications were infections (55.7%), other ones (30.8%), and neoplasms (13.5%). Most of the events were moderate (44.3%), and 36.5% were confirmed. Conclusion: It was possible to identify the scenario of biovigilance in the state, visualizing that the main adverse events are related to the receptor from allogeneic procedures. In addition, the major cause of adverse events in the state of São Paulo are infections, especially those caused by Mycobacterium tuberculosis and Klebsiellapneumoniae. The characterization of these events can support the development of safety strategies to prevent recurrence, the realization of institutional training and public policies to encourage notification and expand the understanding of adverse events in this scenario, since it is only possible to ensure quality and safety in health care, especially in the context of donations and transplants, from the recognition of reality.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Associacao Brasileira de Transplantes de Orgaos
Reference39 articles.
1. 1. World Health Organization (WHO). Conceptual Framework for the International Classification for Patient Safety [Internet]. Genebra: WHO; 2010 [acessado em 14 abr. 2022]. Disponível em: https://apps.who.int/iris/handle/10665/70882
2. 2. Brasil. Portaria nº 529, de 1º de abril de 2013. Institui o Programa Nacional de Segurança do Paciente (PNSP). Diário Oficial da União [Internet]. 2013 [acessado em 14 abr. 2022]. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0529_01_04_2013.html
3. 3. Williams P, Karuppiah S, Greentree K, Darvall J. A checklist for intrahospital transport of critically ill patients improves compliance with transportation safety guidelines. Aust Crit Care [Internet]. 2020 [acessado em 14 abr. 2022];33(1):20-24. Disponível em: https://doi.org/10.1016/j.aucc.2019.02.004
4. 4. Agência Nacional de Vigilância Sanitária (Anvisa). Manual de Biovigilância de células, tecidos e órgãos [Internet]. Brasil: Anvisa; 2020 [acessado em 14 abr. 2022]. Disponível em: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/fiscalizacao-e-monitoramento/biovigilancia/manual-de-biovigilancia-em-celulas-tecidos-e-orgaos-humanos.pdf
5. 5. Brasil. Ministério da Saúde do Brasil. Plataforma para criação de formulários não está mais disponível [Internet]. Brasil: Ministério da Saúde do Brasil; 2021 [acessado em 14 abr. 2022]. Disponível em: http://formsus.datasus.gov.br
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献